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To the Editor:
We read with interest the report by
Khereba and colleagues,1 ‘‘Thoraco-
scopic localization of intraparenchy-
mal pulmonary nodules using direct
intracavitary thoracoscopic ultraso-
nography prevents conversion of
VATS procedures to thoracotomy in
selected patients,’’ which appeared in
the November issue of the Journal.
We congratulate Khereba and col-
leagues1 for their effort in clarifying
the usefulness of this technique in
practice of video-assisted thoraco-
scopic surgery (VATS) for localiza-
tion of intraparenchymal pulmonary
nodules; however, we want to share
some significant concerns we had as
we read their report.
Our first concern pertains to the in-
dications for ultrasonography in pa-
tients with indeterminate pulmonary
nodules. In the study of Khereba and
colleagues,1 27 nodules were found
not more than 1 cm distant from the
pleura on computed tomographic
scan. For these cases, we argue that
they didn’t really need ultrasonogra-
phy to find a lesion just beneath the
pleura, because direct visualization,
palpation byfinger, or a slidingmethod
with an instrument might be helpful in
localization of the target nodule, and
most cases did not require any type of
special localization method.2
Second, in 1 case there was an
unidentifiable nodule with high proba-
bility of malignancy, and a thoraco-
scopic lobectomy was performed
directly. Of course, thoracoscopicThe Journallobectomy is a standard procedure
for unidentifiable nodules with high
probability of malignancy.3 A thora-
coscopic segmentectomy is also en-
couraging with curative purpose,
because survival after thoracoscopic
segmentectomy for small peripheral
non–small cell lung cancer (2 cm)
has been reported to be comparable
to that after thoracoscopic lobec-
tomy.4 In our practice, we have found
direct segmentectomy to be an alter-
native method for management of
those small and indeterminate periph-
eral pulmonary nodules, without the
need to identify the precise location
of the nodules by ultrasonography.
Third, Khereba and colleagues1
concluded that VATS ultrasonography
prevented conversion to thoracotomy
or lobectomy without tissue diagnosis
in 43.5% of cases (20/46). We argue
that if precise location of the target
nodule could not be confirmed, would
the 20 cases all have needed to be con-
verted to thoracotomy or lobectomy?
In our practice of dealing with those
so called ‘‘unidentifiable nodules,’’
we haven’t seen such a high conver-
sion rate. Furthermore, even in the
practice of lobectomy by VATS, the
conversion rate was only 2.66%
(11/414) in our group.5
We do agree with Khereba and col-
leagues1 that intracavitary thoraco-
scopic ultrasonography could locate
intrapulmonary nodules with high
sensitivity and specificity. We believe,
however, that just because intracavi-
tary thoracoscopic ultrasonography is
useful does not mean that it should
be done in every case. The practical
value of VATS ultrasonography ap-
pears excessively amplified.
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In our study, patients were recruited
on the basis of the attending general
thoracic surgeon’s impression of diffi-
culty in finding the nodules on reading
the preoperative computed tomo-
graphic scan. Indeed, there were nod-
ules not more than 1 cm from the
visceral pleura; however, these nod-
ules were chosen because of their
small size or nonsolid nature (ground
glass). Patients who had nodules that
were believed to be easily found on
thoracoscopy were not enrolled in
the trial. In fact, a large proportion of
video-assisted thoracoscopic surgical
(VATS) wedge procedures performed
during the study period were per-
formed without the use of ultrasonog-
raphy. We agree with the statement in
the letter that ‘‘just because intracavi-
tary ultrasonography is useful does
not mean that it should be done in ev-
ery case.’’ We do not perform VATS
with ultrasonography in all cases,
only when we cannot find the nodule
with standard techniques.y c Volume 145, Number 4 1151
Letters to the EditorAlthoughweagreewith thecomment
that VATS segmentectomy may be an
alternative to VATS lobectomy in small
peripheral lung cancers, this has not yet
beendefinitivelyprovenand is therefore
not the standard of care for the surgical
treatment of lung cancer in 2012. This
is the subject of an ongoing Cancer
and Leukemia Group B and National
Cancer Institute randomized, multi-
institutional trial. We strongly encour-
age any center performing lung cancer
surgery to enroll in this important and
well–thought out trial (clinicaltrials.
gov identifier NCT00499330; http://
www.clinicaltrials.gov/ct2/show/NCT
00499330?term¼altorki&rank¼5).
The third comment is hard to an-
swer, and I believe notwell understood
by Liu and colleagues themselves. We1152 The Journal of Thoracic andcould not find the nodules by standard
techniques in 43% of patients, and
these nodules were then found by
VATS with ultrasonography. The
statement that we made in the article
was not that if the nodules were unable
to be found with standard techniques
and a VATS lobectomy was chosen
that the conversion rate to an open pro-
cedure would be high. In fact, our con-
version rate from VATS lobectomy to
open lobectomy is 1%.Wewere trying
tomake the point that if a nodule could
not be found by standard VATS tech-
niques, if VATS with ultrasonography
had not been not available, a decision
would have been required by the sur-
geon during the operation either to per-
form a thoracotomy and palpate the
lung to wedge the nodule out forCardiovascular Surgery c April 2013diagnosis or to perform a blind VATS
lobectomy for tissue diagnosis. We
do not knowwhat would have actually
happened in these cases, nor do we
know the conversion rate from VATS
to open procedures for these cases, be-
cause the nodules were indeed found
with VATS with ultrasonography and
therefore a VATS wedge resection
was performed.
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